A Shot in the Arm? Collegium Pharmaceuticals' Remarkable Quarter and What It Spells for the Future
India Inc.'s Report Card: Unpacking the Q2 Earnings Rollercoaster
AbbVie's High-Stakes Forecast: A Boost That Still Left the Market Wanting More
Concord Drugs Soars: Triple-Digit Growth Ignites Q1 FY25 Performance